2020
Mortality and readmission in non-ischemic compared with ischemic cardiomyopathies after implantable cardioverter-defibrillator implantation
Freeman J, Bjerre J, Parzynski C, Minges K, Ahmad T, Desai N, Enriquez A, Spatz E, Friedman D, Curtis J, Hlatky M, Higgins A. Mortality and readmission in non-ischemic compared with ischemic cardiomyopathies after implantable cardioverter-defibrillator implantation. European Heart Journal 2020, 41: ehaa946.0788. DOI: 10.1093/ehjci/ehaa946.0788.Peer-Reviewed Original ResearchNon-ischemic cardiomyopathyImplantable cardioverter defibrillator implantationPrimary prevention ICDsCardioverter-defibrillator implantationIschemic cardiomyopathyICM patientsNational Cardiovascular Data Registry ICD RegistryCox proportional hazards regression modelPrimary prevention ICD implantationLeft ventricular ejection fractionProportional hazards regression modelsOne-year mortalityHeart failure readmissionVentricular ejection fractionKaplan-Meier curvesHazards regression modelsRisk of mortalityMedian followCause readmissionICD implantationEjection fractionHeart failureHospital readmissionICD RegistryPatient subgroups
2014
Management of Hypertrophic Cardiomyopathy
Enriquez AD, Goldman ME. Management of Hypertrophic Cardiomyopathy. Annals Of Global Health 2014, 80: 35-45. PMID: 24751563, DOI: 10.1016/j.aogh.2013.12.004.Peer-Reviewed Original ResearchConceptsSudden cardiac deathHypertrophic cardiomyopathyHeart failureAtrial fibrillationHCM patientsManagement of HCMCommon genetic cardiovascular diseaseUnexplained myocardial hypertrophyAlcohol septal ablationOutflow tract obstructionRhythm control strategyPathophysiology of HCMRisk of thromboembolismMajority of patientsGeneral adult populationGenetic cardiovascular diseaseAutosomal dominant diseaseFamily membersSurgical myectomyRefractory symptomsRestrictive physiologySeptal ablationTract obstructionYounger patientsCardiac death